BPC-157 & TB-500

The product page lists catalog lot, appearance and storage notes for BPC-157 & TB-500. Available original reports are labelled by sample; matching current certification is unavailable where the compound, lot or amount differs. A heavy-metals screen does not measure purity or confirm identity.

Follow the label and your laboratory's written procedures. Do not treat a historical sample report as current lot documentation. This page repeats 2-8 C storage guidance and light-protection notes before checkout.

BPC-157 and TB-500 are distinct compounds often studied around the same topic - tissue repair. One unit is one vial containing a 10 mg blend. Pack options count vials; each compound has its own research history.

We make no such claim. One 2026 rat study (Biçer et al.) included both, and this page draws no combined effect from it. They're supplied as a 10 mg blend in one vial; matching current certification is unverified.

No. Both are supplied for laboratory research only, 21+ only, and not for human or animal consumption. Neither is approved by any medicines regulator.

One vial contains a 10 mg blend of two research peptides: BPC-157, a 15-amino-acid peptide (GEPPPGKPADDAGLV), and TB-500, a 7-amino-acid fragment (Ac-LKKTETQ) of the protein thymosin beta-4. They have different research histories; one unit is one vial, and pack options count vials. Both are for laboratory research only.

Form Labs makes no such claim. One 2026 rat study (Biçer et al., Joint Diseases and Related Surgery) included both BPC-157 and TB-500; Form Labs draws no combined effect from it. The two are otherwise studied separately, in cell and animal models. The product is supplied as a 10 mg blend in one vial; this is no claim of a shared effect.

BPC-157 is a 15-amino-acid peptide based on a partial sequence of a protein in gastric juice. In published research it's studied - mostly in rodents and cell cultures - for its possible role in how the gut lining, tendons and blood vessels repair. BPC-157 isn't an approved medicine, and there are no completed human trials.

TB-500 is a 7-amino-acid fragment (Ac-LKKTETQ) of the protein thymosin beta-4. In published research it - more often the full protein - is studied for cell movement, wound repair and blood-vessel growth, almost entirely in cell and animal models. TB-500 isn't the full protein, isn't an approved medicine, and has no published human trials of the fragment.

They're unrelated compounds. BPC-157 is a 15-amino-acid peptide (GEPPPGKPADDAGLV) based on a protein in gastric juice, studied mostly in gut, tendon and blood-vessel models. TB-500 is a 7-amino-acid fragment (Ac-LKKTETQ) of thymosin beta-4, studied mostly for cell movement and repair. Different origins, different sequences, different research.

BPC-157 and TB-500 are both Schedule 4 substances in Australia. The October 2026 Poisons Standard (checked 1 October 2026) lists each in Schedule 4 and in Appendix D, clause 5 - the appendix for poisons whose possession without authority is illegal. The TGA's April 2026 examples of unapproved peptide products name both, and Sport Integrity Australia lists both as prohibited in sport. Form Labs supplies both strictly as laboratory research material, not for human or veterinary use.

No. Neither compound has been approved as a medicine by any regulator - not the TGA in Australia, the FDA in the United States, or the EMA in Europe - for any use. Both remain investigational research compounds, and Form Labs sells the set only as reference material for laboratory research.

Not in completed, published trials. BPC-157's first controlled human trial (NCT07437547) only began in 2026, with results expected around 2027; a TB-500 safety study (NCT07487363) is recruiting but has no results. For both compounds, today's evidence is almost entirely from cell and animal research.

The historical Janoshik report on file covers a 10 mg BPC-157 and TB-500 blend and is a heavy-metals screen: it reports arsenic, cadmium and mercury as not detected. It does not measure purity, does not confirm identity, and does not test for bacterial residue. The report covers its named sample lot, which differs from the listed catalog lot.

The research-peptide market is largely unregulated, and independent analyses have repeatedly found products that are under-strength, mislabelled or contaminated. Read each available report against its named sample; it does not verify a different lot or establish current purity or identity. It's also why both should be handled only as research materials.

The BPC-157 and TB-500 set ships from Perth via Australia Post or CouriersPlease in plain, unbranded packaging once your payment clears, with tracking emailed. On arrival, store the freeze-dried vials in the fridge at 2-8 C and keep them out of light. Delivery is Australia-only; a flat rate applies, with free standard shipping on orders of $250 or more.

Add the set to your cart and check out. Instead of paying by card, you'll receive an emailed invoice with our bank details - pay by bank transfer, quoting the reference. Once the payment clears we pack and send your order, and email you tracking. A faster transfer (PayID or Osko) gets things moving sooner.

This blend carries the 30-day purity guarantee. If an independent lab re-tests the batch within 30 days of your order and finds it below the purity stated on the COA supplied with the order or available on request, we refund the order in full - and you don't need to send the vial back.

No. BPC-157 and TB-500 are supplied strictly as reference materials for laboratory research - not medicines, supplements or food, and not for people or animals to take, and 21+ only. The research described on this page concerns the two molecules in published studies, not a Form Labs product.